Urgent Product Information Bulletin:
Takeda Pharmaceutical Co. has agreed to a $2.4 billion settlement to resolve bladder cancer claims resulting from Actos use. The settlement was designed to compensate claimants based upon the extent of their injuries and their cumulative exposure to Actos, taking into account risk factors that may have caused or contributed to the diagnosis of bladder cancer.
To be eligible to participate, a claimant must have taken Actos prior to December 1, 2011, been diagnosed with bladder cancer, and either have a suit pending or have signed an attorney contract no later than noon Eastern Standard Time May 1, 2015. If eligible and in order to participate in the $2.4 billion settlement fund, please contact Sherrod & Bernard, P.C., before Friday, May 1, 2015.
